German cancer specialist Immatics has priced a $150 million public offering with Jefferies, BofA Securities, and Leerink as ...

Berlin, Germany-based Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines ...

The UK's MHRA has approved Pfizer and BioNTech's updated COVID-19 vaccine, Comirnaty (KP.2), for use in adults. This approval ...

South Korea’s Samsung Bioepis has released its Fourth Quarter 2024 Biosimilar Market Report, marking the seventh-edition of ...

Gritstone bio has filed for bankruptcy following disappointing Phase II data from its study of the personalized neoantigen ...

Insitro has signed three strategic agreements with Eli Lilly aimed at advancing treatments for metabolic diseases like MASLD, ...

US pharma giant Pfizer today released positive top line results from the final prespecified overall survival (OS) analysis of ...

Johnson & Johnson’s Tecvayli (teclistamab) has been recommended by NICE as a first-line treatment for myeloma in England and ...

Black Diamond Therapeutics (Nasdaq: BDTX) is restructuring to focus on its lead drug, BDTX-1535, aimed at non-small cell lung ...

Nanoscope Therapeutics says that, following a productive FDA meeting with the US Food and Drug Administration (FDA) for its ...

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Applications for AVT03, a proposed ...

Beijing’s InnoCare Pharma has announced promising Phase II results for its TYK2 inhibitor, ICP-488, in moderate-to-severe ...